Organon Co Stock Market Value
OGN Stock | USD 20.75 0.21 1.00% |
Symbol | Organon |
Organon Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.13 | Dividend Share 1.12 | Earnings Share 4.08 | Revenue Per Share 24.835 | Quarterly Revenue Growth 0.055 |
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Organon 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Organon's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Organon.
05/08/2024 |
| 06/07/2024 |
If you would invest 0.00 in Organon on May 8, 2024 and sell it all today you would earn a total of 0.00 from holding Organon Co or generate 0.0% return on investment in Organon over 30 days. Organon is related to or competes with Johnson Johnson, Bristol Myers, AbbVie, Eli Lilly, Pfizer, Amgen, and Merck. Organon Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies... More
Organon Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Organon's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Organon Co upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.72 | |||
Information Ratio | 0.1696 | |||
Maximum Drawdown | 8.26 | |||
Value At Risk | (2.55) | |||
Potential Upside | 2.55 |
Organon Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Organon's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Organon's standard deviation. In reality, there are many statistical measures that can use Organon historical prices to predict the future Organon's volatility.Risk Adjusted Performance | 0.1258 | |||
Jensen Alpha | 0.3032 | |||
Total Risk Alpha | 0.2399 | |||
Sortino Ratio | 0.1646 | |||
Treynor Ratio | 1.62 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Organon's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Organon Backtested Returns
Organon appears to be very steady, given 3 months investment horizon. Organon maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Organon, which you can use to evaluate the volatility of the company. Please evaluate Organon's Coefficient Of Variation of 523.55, risk adjusted performance of 0.1258, and Semi Deviation of 1.52 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Organon holds a performance score of 10. The company holds a Beta of 0.19, which implies not very significant fluctuations relative to the market. As returns on the market increase, Organon's returns are expected to increase less than the market. However, during the bear market, the loss of holding Organon is expected to be smaller as well. Please check Organon's downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Organon's historical price patterns will revert.
Auto-correlation | -0.23 |
Weak reverse predictability
Organon Co has weak reverse predictability. Overlapping area represents the amount of predictability between Organon time series from 8th of May 2024 to 23rd of May 2024 and 23rd of May 2024 to 7th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Organon price movement. The serial correlation of -0.23 indicates that over 23.0% of current Organon price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.23 | |
Spearman Rank Test | -0.44 | |
Residual Average | 0.0 | |
Price Variance | 0.06 |
Organon lagged returns against current returns
Autocorrelation, which is Organon stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Organon's stock expected returns. We can calculate the autocorrelation of Organon returns to help us make a trade decision. For example, suppose you find that Organon has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Organon regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Organon stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Organon stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Organon stock over time.
Current vs Lagged Prices |
Timeline |
Organon Lagged Returns
When evaluating Organon's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Organon stock have on its future price. Organon autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Organon autocorrelation shows the relationship between Organon stock current value and its past values and can show if there is a momentum factor associated with investing in Organon Co.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Organon Stock
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:Check out Organon Correlation, Organon Volatility and Organon Alpha and Beta module to complement your research on Organon. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Organon technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.